NCT00316680View on ClinicalTrials.gov

Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.

PHASE3TerminatedINTERVENTIONAL

Enrollment

288

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

November 30, 2006

Conditions

Haemophilus Influenzae Type bDiphtheriaTetanusHepatitis BWhole Cell Pertussis

Interventions

BIOLOGICAL

Diphtheria, tetanus, pertussis, hepatitis B, Hib vaccine

Trial Locations (1)

Unknown

GSK Investigational Site, Santo Domingo

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00316680 - Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age. | Biotech Hunter | Biotech Hunter